A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

This study has been completed.

Study NCT00050830 Information provided by Pfizer

First Received: December 20, 2002 Last Updated: November 6, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	November 2005
Estimated Primary Completion Date:	No date given